FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3179169714> ?p ?o ?g. }

• W3179169714 endingPage "1391" @default.
• W3179169714 startingPage "1381" @default.
• W3179169714 abstract "Abstract Several studies have showed that combining peg‐interferon alpha (Peg‐IFNα) with nucleotide analogues has complementary effects in chronic hepatitis B (CHB), but the optimal regimen and potential mechanisms remain unclear. This was a prospective, longitudinal and multicentre clinical trial (NCT03013556). HBeAg‐positive CHB naïve patients were randomly assigned to three groups: tenofovir disoproxil fumarate (TDF) monotherapy for 96 weeks, TDF alone for 48 weeks and sequentially Peg‐IFNα added for 48 weeks, TDF de novo combination with Peg‐IFNα for 48 weeks then TDF alone for 48 weeks. The primary endpoint was HBeAg seroconversion at week 96 and HBsAg loss as the secondary endpoint. Furthermore, the levels of 12 cytokines in serum were assessed at different time points. A total of 133 patients were included in the analysis. The rates of HBeAg seroconversion at 96 weeks were not significant different among the three groups ( p = 0.157). Interestingly, patients in the Peg‐IFNα add‐on group showed markedly lower HBsAg level compared with the other two groups at week 96. In addition, only three patients in the Peg‐IFNα add‐on group achieved HBsAg loss. For the following 24 weeks from week 96, no HBsAg reappearance in the three patients and no new patients with HBsAg loss were observed in the three groups. Serum cytokine analysis showed that the baseline level of interferon‐inducible protein‐10 (IP‐10) was strongly higher in HBeAg conversion patients and HBsAg loss patients. Compared with de novo combination and TDF alone, the addition of Peg‐IFNα in TDF‐treated group might be an effective strategy for HBsAg loss in HBeAg‐positive CHB naïve patients." @default.
• W3179169714 created "2021-07-19" @default.
• W3179169714 creator A5009492388 @default.
• W3179169714 creator A5018411968 @default.
• W3179169714 creator A5019604775 @default.
• W3179169714 creator A5020040782 @default.
• W3179169714 creator A5022056998 @default.
• W3179169714 creator A5035441171 @default.
• W3179169714 creator A5036487272 @default.
• W3179169714 creator A5037050291 @default.
• W3179169714 creator A5040234558 @default.
• W3179169714 creator A5042402054 @default.
• W3179169714 creator A5047258558 @default.
• W3179169714 creator A5052228162 @default.
• W3179169714 creator A5058260994 @default.
• W3179169714 creator A5058298924 @default.
• W3179169714 creator A5061130250 @default.
• W3179169714 creator A5076246718 @default.
• W3179169714 creator A5082464514 @default.
• W3179169714 date "2021-07-14" @default.
• W3179169714 modified "2023-09-27" @default.
• W3179169714 title "Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients" @default.
• W3179169714 cites W1675657702 @default.
• W3179169714 cites W1976643312 @default.
• W3179169714 cites W1994529038 @default.
• W3179169714 cites W1995915978 @default.
• W3179169714 cites W1998464118 @default.
• W3179169714 cites W2005593266 @default.
• W3179169714 cites W2008517556 @default.
• W3179169714 cites W2010681459 @default.
• W3179169714 cites W2020276240 @default.
• W3179169714 cites W2024940442 @default.
• W3179169714 cites W2029180341 @default.
• W3179169714 cites W2036627386 @default.
• W3179169714 cites W2044276375 @default.
• W3179169714 cites W2044951291 @default.
• W3179169714 cites W2048353858 @default.
• W3179169714 cites W2063241624 @default.
• W3179169714 cites W2063885826 @default.
• W3179169714 cites W2064823659 @default.
• W3179169714 cites W2077060471 @default.
• W3179169714 cites W2080056304 @default.
• W3179169714 cites W2089247679 @default.
• W3179169714 cites W2093189109 @default.
• W3179169714 cites W2101669500 @default.
• W3179169714 cites W2119746503 @default.
• W3179169714 cites W2164831271 @default.
• W3179169714 cites W2171150690 @default.
• W3179169714 cites W2172066280 @default.
• W3179169714 cites W2173007581 @default.
• W3179169714 cites W2174723704 @default.
• W3179169714 cites W2324172885 @default.
• W3179169714 cites W2345440510 @default.
• W3179169714 cites W2570944843 @default.
• W3179169714 cites W2577526874 @default.
• W3179169714 cites W2587599161 @default.
• W3179169714 cites W2596506481 @default.
• W3179169714 cites W2605785536 @default.
• W3179169714 cites W2791372726 @default.
• W3179169714 cites W2791839818 @default.
• W3179169714 cites W2792971851 @default.
• W3179169714 cites W2913926637 @default.
• W3179169714 cites W3043456232 @default.
• W3179169714 doi "https://doi.org/10.1111/jvh.13571" @default.
• W3179169714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34228855" @default.
• W3179169714 hasPublicationYear "2021" @default.
• W3179169714 type Work @default.
• W3179169714 sameAs 3179169714 @default.
• W3179169714 citedByCount "3" @default.
• W3179169714 countsByYear W31791697142022 @default.
• W3179169714 crossrefType "journal-article" @default.
• W3179169714 hasAuthorship W3179169714A5009492388 @default.
• W3179169714 hasAuthorship W3179169714A5018411968 @default.
• W3179169714 hasAuthorship W3179169714A5019604775 @default.
• W3179169714 hasAuthorship W3179169714A5020040782 @default.
• W3179169714 hasAuthorship W3179169714A5022056998 @default.
• W3179169714 hasAuthorship W3179169714A5035441171 @default.
• W3179169714 hasAuthorship W3179169714A5036487272 @default.
• W3179169714 hasAuthorship W3179169714A5037050291 @default.
• W3179169714 hasAuthorship W3179169714A5040234558 @default.
• W3179169714 hasAuthorship W3179169714A5042402054 @default.
• W3179169714 hasAuthorship W3179169714A5047258558 @default.
• W3179169714 hasAuthorship W3179169714A5052228162 @default.
• W3179169714 hasAuthorship W3179169714A5058260994 @default.
• W3179169714 hasAuthorship W3179169714A5058298924 @default.
• W3179169714 hasAuthorship W3179169714A5061130250 @default.
• W3179169714 hasAuthorship W3179169714A5076246718 @default.
• W3179169714 hasAuthorship W3179169714A5082464514 @default.
• W3179169714 hasConcept C10138342 @default.
• W3179169714 hasConcept C126322002 @default.
• W3179169714 hasConcept C159654299 @default.
• W3179169714 hasConcept C162324750 @default.
• W3179169714 hasConcept C203014093 @default.
• W3179169714 hasConcept C203092338 @default.
• W3179169714 hasConcept C2522874641 @default.
• W3179169714 hasConcept C2775940106 @default.
• W3179169714 hasConcept C2776178377 @default.
• W3179169714 hasConcept C2776461080 @default.

• next